Transplantation News

WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results that assessed the relationship between gout and return to hemodialysis among patients who had a kidney transplant. Researchers found patients who developed gout after transplantation were more likely to need maintenance hemodialysis compared with patients without gout and those with preexisting gout.

BOSTON — Hepatitis C infection was prevented or rapidly cured in transplant recipients who received organs from donors infected with the virus following combined treatment with ezetimibe and direct-acting antiviral therapy, according to study results presented at The Liver Meeting 2019.

WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results of a study on renal transplant patients that found those with gout had increased rates of transplant-related complications.

WASHINGTON — ANG-3777, a hepatocyte growth factor mimetic, may be an effective treatment for delayed graft function in patients undergoing kidney transplant, according to study results presented at ASN Kidney Week.

Most nephrologists agree that a kidney transplant is the optimal choice for a patient with kidney disease — either preemptively or from a living or decreased donor. However, a study recently published in JAMA suggests the likelihood of a patient receiving any of those options or being referred for an evaluation can be influenced by who owns the dialysis facility.

Donate Life America and the Fresenius Medical Care Foundation recently announced the groups would launch a national, universal living donor kidney registry and at-home testing kit to improve access to living donation.

Newly published findings suggest that while increased utilization of “high-risk” kidneys was associated with shorter time to transplantation, there was substantial variation in acceptance patterns among centers.

According to a recently published study, implementing a policy that requires citizens to “opt-out” of being an organ donor may help increase both the number of transplants performed and candidate life-years gained, especially for those awaiting kidney transplantation.

Receiving kidney transplantation at high-volume centers did not demonstrate improved graft or patient survival compared with transplantation at low-volume centers, according to a published study.

Patients living with HIV who received kidney transplants from donors with HIV had high rates of overall survival and kidney graft survival after 5 years, with no evidence of sustained superinfection, according to study findings from South Africa, which pioneered HIV-to-HIV kidney transplants just over a decade ago.